Latest Wholesale News

Liberty Group delivered a second consecutive year of profit growth in FY26 as record loan originations lifted financial assets to A$15.2 billion. The result supports a 15-cent fully franked special dividend, although credit provisions and cash flow remain important tests for the lending model.

APA Group will invest approximately $1.015 billion for an 80% stake in a new 400MW gas peaking plant in Queensland, backed by a 25-year inflation-linked hedge with CS Energy. The Brigalow project is targeted for completion in early 2029 and expands APA’s contracted power generation portfolio.

Macquarie Global Small Companies Fund reported a A$561,000 operating profit in its first financial period after launching three unit classes in June. The fund ended the period with A$11.757 million in net assets, although its short start-up period offers little basis for judging full-year performance.

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Global X Gold Bullion ETF reported a AUD 1.07 million loss for the year ended 30 June 2026, despite net assets rising to AUD 621.9 million. The fund also disclosed a lower management fee from September.

Spacetalk Limited (ASX:SPA) has posted a sharply deeper FY26 loss and negative net assets, while its auditor flagged a material uncertainty over the company’s ability to continue as a going concern. The company says a $10 million post-year-end placement, note conversions and new telco agreements give its software-led strategy room to execute.

PIMCO Short Term Active Yield Fund grew net assets nearly eightfold to A$239.8 million in the year to 30 June 2026, as its ASX-listed EARN ETF class attracted new capital. All reported unit classes outperformed the fund’s cash-rate benchmark, although the ETF’s 3.11% return covers only nine months.

Memphasys says it has identified a potential FDA 510(k) pathway for its Felix sperm separation system, replacing the more complex De Novo route previously contemplated. The company will seek FDA feedback before targeting a formal submission in the first quarter of 2027, while keeping commercial execution focused on existing markets.

HealthCo Healthcare and Wellness REIT (ASX: HCW) reported a $49.7 million FY26 statutory loss, suspended distributions and received an unmodified audit opinion that nevertheless highlighted a material uncertainty over its ability to continue as a going concern. The key unresolved issue is the transfer of 10 Healthscope hospitals to alternative operators.

Financial Income Fund delivered a 6.78% net return in the year to 30 June 2026, beating its hybrid securities benchmark by 0.92 percentage points. The audited report also records the launch of an ETF class, higher distributions and a shift away from convertible notes.

PaySauce has moved its Global Payroll Platform from development into commercial operation in Australia, while first-quarter FY27 ARR rose 8% to $9.5 million. The expansion is supported by a stronger cash position, but higher customer acquisition costs and lower profitability leave execution firmly in focus.

Zimi has secured an exclusive three-year distribution agreement with Directed for retail, direct-to-consumer and direct-to-business sales across Australia and New Zealand. The deal gives its next-generation Matter devices access to more than 10,000 retail outlets, although commercial terms and guaranteed sales volumes remain undisclosed.